Gilead Sciences Inc (GILD)
89.83
+1.20
(+1.35%)
USD |
NASDAQ |
Nov 21, 12:52
Gilead Sciences Debt to Equity Ratio: 1.258 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.258 |
| June 30, 2024 | 1.277 |
| March 31, 2024 | 1.436 |
| December 31, 2023 | 1.094 |
| September 30, 2023 | 1.120 |
| June 30, 2023 | 1.193 |
| March 31, 2023 | 1.202 |
| December 31, 2022 | 1.188 |
| September 30, 2022 | 1.196 |
| June 30, 2022 | 1.296 |
| March 31, 2022 | 1.315 |
| December 31, 2021 | 1.267 |
| September 30, 2021 | 1.290 |
| June 30, 2021 | 1.532 |
| March 31, 2021 | 1.592 |
| December 31, 2020 | 1.725 |
| September 30, 2020 | 1.679 |
| June 30, 2020 | 1.337 |
| March 31, 2020 | 1.092 |
| December 31, 2019 | 1.092 |
| September 30, 2019 | 1.193 |
| June 30, 2019 | 1.153 |
| March 31, 2019 | 1.211 |
| December 31, 2018 | 1.278 |
| September 30, 2018 | 1.195 |
| Date | Value |
|---|---|
| June 30, 2018 | 1.341 |
| March 31, 2018 | 1.411 |
| December 31, 2017 | 1.641 |
| September 30, 2017 | 1.178 |
| June 30, 2017 | 1.160 |
| March 31, 2017 | 1.288 |
| December 31, 2016 | 1.395 |
| September 30, 2016 | 1.605 |
| June 30, 2016 | 1.424 |
| March 31, 2016 | 1.703 |
| December 31, 2015 | 1.19 |
| September 30, 2015 | 1.276 |
| June 30, 2015 | 0.7536 |
| March 31, 2015 | 0.7196 |
| December 31, 2014 | 0.8041 |
| September 30, 2014 | 0.6936 |
| June 30, 2014 | 0.5907 |
| March 31, 2014 | 0.7323 |
| December 31, 2013 | 0.5836 |
| September 30, 2013 | 0.672 |
| June 30, 2013 | 0.6615 |
| March 31, 2013 | 0.7878 |
| December 31, 2012 | 0.8841 |
| September 30, 2012 | 1.020 |
| June 30, 2012 | 1.137 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.092
Minimum
Dec 2019
1.725
Maximum
Dec 2020
1.309
Average
1.272
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.185 |
| Merck & Co Inc | 0.8568 |
| Pfizer Inc | 0.7219 |
| Vertex Pharmaceuticals Inc | 0.00 |
| Amgen Inc | 8.024 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 54.52B |
| Total Liabilities (Quarterly) | 36.14B |
| Shareholders Equity (Quarterly) | 18.47B |
| Current Ratio | 1.261 |
| Net Debt Paydown Yield | 0.38% |